There is mounting evidence to suggest GLP-1 drugs designed as diabetes and obesity treatments also help reduce cancer risk. There's mounting evidence suggesting that GLP-1 drugs also help reduce ...

GLP-1s are prescribed for a growing number of conditions and come with a range of side effects — including ones that lawsuits allege are life-altering or lethal. How common is that? It's hard to know.

GLP-1 drugs are meant to treat metabolic diseases like diabetes and obesity. But as they become more available, some people might choose to use them even if they're not currently overweight. NPR's ...

The nation's outbreak of cyclosporiasis has far surpassed previous records. The CDC counts more than 4,100 cases in the U.S. so far this year. And as NPR's Yuki Noguchi reports, health officials are ...

Play is how we evolved to learn, solve problems, and navigate the world. So why do we treat it as optional? This hour, the ...

The record-breaking cyclospora outbreak with over 4,100 confirmed cases comes more than a year after the Trump administration started slashing public health funding. NPR's Yuki Noguchi reports on how ...

Lung cancer is still the top cancer killer. But new developments are shifting what the future might hold for patients, as one man's cancer journey shows. NPR's Yuki Noguchi reports. YUKI NOGUCHI, ...

There's mounting evidence suggesting that GLP-1 drugs also help reduce cancer risk. NPR's Yuki Noguchi reports that several recent studies find a strong correlation, but now the question is - why?